Literature DB >> 8240562

Complete heart block in a child with varicella.

R Rich1, M McErlean.   

Abstract

A case of varicella myocarditis in a previously healthy 6-year-old child was reviewed. The patient presented with third-degree heart block and shock as the sole manifestation of her cardiac involvement. Bradyarrhythmias required temporary transvenous pacing. Intravenous acyclovir was used. The patient recovered without permanent sequelae. The natural history, clinical presentation, and treatment of varicella myocarditis are reviewed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240562     DOI: 10.1016/0735-6757(93)90011-y

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Complications of varicella zoster.

Authors:  Kivilcim Gücüyener; Elvan Cağlar Citak; Murat Elli; Ayse Serdaroğlu; Funda Erkasar Citak
Journal:  Indian J Pediatr       Date:  2002-02       Impact factor: 1.967

2.  Complete heart block in a 5-year-old child with varicella and acute thrombocytopenic purpura.

Authors:  Arani Sridhar; Anil Sapare; Srinivas Parepalli; Jonathan Acheson
Journal:  BMJ Case Rep       Date:  2012-01-03

3.  Myopericarditis associated with varicella zoster virus infection.

Authors:  Kai-Liang Kao; Shu-Jen Yeh; Chia-Chun Chen
Journal:  Pediatr Cardiol       Date:  2010-01-20       Impact factor: 1.655

Review 4.  The clinical course of acquired complete heart block in children with acute myocarditis.

Authors:  A S Batra; D Epstein; M J Silka
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

5.  Junctional ectopic tachycardia following complete heart block associated with viral myocarditis.

Authors:  J A Maiers; E S Ebenroth
Journal:  Pediatr Cardiol       Date:  2006 May-Jun       Impact factor: 1.838

Review 6.  What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal Studies.

Authors:  Gary Tse; Jie M Yeo; Yin Wah Chan; Eric T H Lai Lai; Bryan P Yan
Journal:  Front Physiol       Date:  2016-07-21       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.